Harris will campaign with the Obamas later this month in Georgia and Michigan
Fuji Soft board supports KKR buyout offer, Nikkei reports
Hot meals, hot tempers: The struggles of China’s food delivery drivers
Lebanese PM says he rejects Iranian interference in Lebanese matter
Hong Kong's July-September unemployment rate holds steady at 3%
Mets look for biggest comeback yet after falling behind Dodgers 3-1 in NLCS
Mountain West commissioner says she's heartbroken over turmoil surrounding San Jose State volleyball
Ohtani and Betts lead Dodgers to latest blowout of Mets for 3-1 lead in lopsided NLCS
(Reuters) - The manufacturers of drugs selected for the U.S. Medicare program's pricing negotiations have submitted counter offers to the U.S. government's initial proposal, U.S. President Joe Biden said on Monday.
The Biden administration sent its initial offers to manufacturers of 10 high-cost medicines, which include Bristol Myers Squibb and Pfizer's PFE.N blood thinner Eliquis, in February.
(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)
